Search

Your search keyword '"Boukari, L."' showing total 2 results
Start Over Author "Boukari, L." Topic hepatitis
2 results on '"Boukari, L."'

1. [A case of yersiniasis with multiple liver abscesses].

Author

Benbrika S, Boukari L, Stirnemann J, Letellier E, Fain O, Thomas M, and Kettaneh A

Subjects
Drug Therapy, Combination, Humans, Imipenem administration & dosage, Imipenem therapeutic use, Male, Middle Aged, Ofloxacin administration & dosage, Ofloxacin therapeutic use, Radiography, Abdominal, Time Factors, Tomography, X-Ray Computed, Diabetes Mellitus, Type 1 complications, Hemochromatosis complications, Hepatitis diagnosis, Hepatitis diagnostic imaging, Liver Abscess diagnosis, Liver Abscess diagnostic imaging, Liver Abscess drug therapy, Yersinia Infections diagnosis, Yersinia Infections drug therapy, Yersinia enterocolitica isolation & purification
Published
2005
Full Text
View/download PDF

2. Hépatite aiguë médicamenteuse à l’anakinra chez une patiente traitée pour une maladie de Still de l’adulte

Author

Diallo, A., Mekinian, A., Boukari, L., Mouas, H., Zamy, M., Nahon, P., Gérin, M., and Fain, O.

Subjects
*HEPATITIS treatment, *INTERLEUKIN-1 receptor antagonist protein, *DRUG efficacy, *CASE studies, *SERUM, *JUVENILE idiopathic arthritis, *DIAGNOSIS, *THERAPEUTICS
Abstract

Abstract: Introduction: Adult-onset Still''s disease is characterized by non-specific polymorphic features. The efficacy of anakinra, an IL-1 receptor antagonist, has been shown in several studies. This medication is well-tolerated, and only one case of severe hepatitis has been previously reported. Case report: A 22-year-old woman presented with fever, rash, arthritis, and pericarditis, associated with systemic inflammatory response syndrome and elevated ferritin serum level with low glycosylated ferritin. Adult-onset Still''s disease was diagnosed, but treatment with steroids did not achieve remission. The patient was then treated with anakinra, which resulted in spectacular improvement, but 3 weeks after the initiation of the treatment she experienced severe hepatitis that resolved after the discontinuation of anakinra. Conclusion: Hepatitis is a rare side effect of anakinra and the monitoring of liver tests should be recommended during anakinra therapy. [Copyright &y& Elsevier]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results